Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
FLAGYL
Generic name / active ingredient
metronidazole
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral
Record reviewed
2026-08-24

Copy from the pack in hand

Source-linked reading points

  • Check FLAGYL, metronidazole, 375 mg per capsule, oral-capsule form, NDC 0025-1942-50, the 50-capsule bottle and target market together. 375 mg is the labelled amount in each exact capsule and 50 is the pack count; neither is a web answer for personal use, course length or conversion to another metronidazole product.
  • The label context treats capsules, tablets, injections, vaginal products and other anti-infectives as different product questions. A matching generic name, similar package, shared mg wording or the label 'antibacterial' does not establish self-directed form changes, combination, alternation, leftover use or starting treatment for a similar symptom.
  • The label identifies matters to check involving alcohol or propylene-glycol-containing products, warfarin and other oral coumarin anticoagulants, and flags serious skin reactions among other risks. Give all prescription medicines, OTC products, supplements and actual packs to a pharmacist or prescriber for item-by-item review; a webpage cannot turn these warnings into an individual's 'can/cannot use' or stopping plan.
  • With widespread rash, blisters, fever, mucosal changes, severe abdominal pain, fainting, breathing difficulty or another acute serious concern, prioritise local medical support; do not wait for a web response or test the cause by stopping and changing several medicines at once.

Reviewed presentation examples — compare every field

  • 375 mg per capsule; 50-capsule bottleNDC 0025-1942-50

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-24
Source record
2 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image